全文获取类型
收费全文 | 1409244篇 |
免费 | 94523篇 |
国内免费 | 2046篇 |
专业分类
耳鼻咽喉 | 22314篇 |
儿科学 | 46752篇 |
妇产科学 | 43520篇 |
基础医学 | 211913篇 |
口腔科学 | 38472篇 |
临床医学 | 114632篇 |
内科学 | 277904篇 |
皮肤病学 | 32382篇 |
神经病学 | 108571篇 |
特种医学 | 55560篇 |
外国民族医学 | 366篇 |
外科学 | 217548篇 |
综合类 | 27174篇 |
现状与发展 | 1篇 |
一般理论 | 311篇 |
预防医学 | 97717篇 |
眼科学 | 34168篇 |
药学 | 102684篇 |
1篇 | |
中国医学 | 2546篇 |
肿瘤学 | 71277篇 |
出版年
2018年 | 12094篇 |
2015年 | 14693篇 |
2014年 | 19650篇 |
2013年 | 29226篇 |
2012年 | 37299篇 |
2011年 | 39537篇 |
2010年 | 24858篇 |
2009年 | 23721篇 |
2008年 | 38703篇 |
2007年 | 41477篇 |
2006年 | 42460篇 |
2005年 | 41288篇 |
2004年 | 39569篇 |
2003年 | 37187篇 |
2002年 | 35644篇 |
2001年 | 59009篇 |
2000年 | 60454篇 |
1999年 | 51695篇 |
1998年 | 15360篇 |
1997年 | 13934篇 |
1996年 | 14564篇 |
1995年 | 13950篇 |
1994年 | 13363篇 |
1993年 | 12363篇 |
1992年 | 42637篇 |
1991年 | 41812篇 |
1990年 | 41176篇 |
1989年 | 39893篇 |
1988年 | 37215篇 |
1987年 | 36531篇 |
1986年 | 34797篇 |
1985年 | 33100篇 |
1984年 | 24947篇 |
1983年 | 21659篇 |
1982年 | 13364篇 |
1981年 | 11837篇 |
1980年 | 11035篇 |
1979年 | 23533篇 |
1978年 | 16905篇 |
1977年 | 14519篇 |
1976年 | 13635篇 |
1975年 | 14969篇 |
1974年 | 17480篇 |
1973年 | 16918篇 |
1972年 | 16017篇 |
1971年 | 14838篇 |
1970年 | 13787篇 |
1969年 | 13436篇 |
1968年 | 12537篇 |
1967年 | 11066篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
Is atrial fibrillation an inflammatory disorder? 总被引:2,自引:0,他引:2
I read with great interest the excellent review on the influenceof inflammation in the pathogenesis of atrial fibrillation (AF)by Boos 相似文献
82.
Prof. Dr. Alexander Kapp Prof. Dr. Bettina Wedi 《Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete》2006,57(10):854-854
Ohne Zusammenfassung 相似文献
83.
84.
Chest injuries can be sustained in isolation or in association with multiple injuries. Life-threatening complications may ensue because organs that are vital to survival of the organism are situated within the thoracic cavity. These complications include airway obstruction, tension pneumothorax, wide open pneumothorax, flail chest, cardiac tamponade and massive hemothorax. The mortality of patients hospitalized with chest injury can be as high as 10%. Clinical examination and awareness of the possibility of other injuries (high level of suspicion) are essential, and standard chest X-ray, ultrasound and thoracic computed tomography may also be needed for the diagnosis. The first part of this serial paper on the management of chest injuries focuses on anatomical aspects, pathophysiology and symptoms, but mainly on the indications for the standard diagnostic procedures and further high-tech examinations. 相似文献
85.
M. RAUVALA K. AGLUND† U. PUISTOLA T. TURPEENNIEMI-HUJANEN‡ G. HORVATH§ R. WILLÉN & U. STENDAHL† 《International journal of gynecological cancer》2006,16(3):1297-1302
The incidence of uterine cervical cancer has increased slightly in Western countries, with an increase in relatively young women. Overexpression of matrix metalloproteinases (MMPs)-2 and -9 has turned out as a prognostic factor in many cancers. We compared the expression of the proteins MMP-2 and MMP-9 in cervical primary tumors with clinical outcome and risk factors of cervical cancer. One hundred sixty-one patients with cervical cancer treated in Ume? University Hospital or Sahlgrenska University Hospital, Sweden, between 1991 and 1995 were included in the study. Paraffin-embedded tissue samples obtained prior to treatment were examined immunohistochemically by specific antibodies for MMP-2 and MMP-9. Forty-two percent of the tumors were intensively positive for MMP-2 and 31% for MMP-9. Nineteen percent of the samples were intensively positive for both proteinases and 47% negative or weak for both. Overexpression of MMP-2 seemed to predict unfavorable survival under Kaplan-Meier analysis and in the multivariate analysis. Early sexual activity and low parity seemed to correlate to overexpression of MMP-2. MMP-9 was not associated with survival or sexual behavior. Intensive MMP-9 was noted in grade 1 tumors. We conclude that MMP-2 and MMP-9 have different roles in uterine cervical cancer. MMP-2 could be associated with aggressive behavior, but MMP-9 expression diminishes in high-grade tumors. 相似文献
86.
Andrea R Genazzani Hermann P G Schneider Nick Panay Esme A Nijland 《Gynecological endocrinology》2006,22(7):369-375
OBJECTIVES: To identify and describe current women's thoughts about the menopause, hormone treatment (HT) and perceptions about breast cancer. METHODS: Between December 2004 and January 2005, 4201 postmenopausal women in seven European countries were interviewed via a standardized computer-aided telephone interview protocol. RESULTS: Almost all women reported to have experienced climacteric symptoms, and 63% of the women rated them as being severe. Only 52% of women were aware of the benefits of HT for relief of climacteric symptoms. Although 84% felt that severe symptoms should be treated, only 40% had used HT at some point in time. Thirty-four percent of the women preferring treatment with natural products did so because of the risk of breast cancer associated with HT. HT was recognized by 59% of the women as one of the most important contributors to an increased breast cancer risk. Most women received their information about HT and breast cancer risk from the media. CONCLUSIONS: This European survey reveals that the majority of women experience climacteric symptoms but that their decision whether or not to use HT is highly dependent on their concern about breast cancer risk. An increase in knowledge of the benefits and risks of HT is required for women to make appropriate decisions about hormone use. 相似文献
87.
88.
Prof. Dr. H. Delbrück 《Der Onkologe》2006,12(5):451-459
Rehabilitative and palliative measures in the follow-up care of pancreatic cancer patients will remain the dominant medical focus as long as potentially curative measures (recurrence prophylaxis, early detection and therapy of recurrence) have failed to show a significant survival benefit. Rehabilitative measures are possible for patients undergoing potentially curative as well as palliative treatment. Their aim is to alleviate the negative effects of the cancer and its therapy, not only physically, but also psychologically, socially and vocationally. The spectrum of possible somatic handicaps ranges from metabolic disorders, malnutrition and under-nutrition, as well as gastrointestinal symptoms to pain. Assistance in coping with illness, alleviating fears and depression and strengthening compliance are the main areas which are dealt with in psycho-oncology. Assessment of vocational fitness and the capacity to work depends on tumor location, whether R0 or R1 resection has taken place, the extent of pancreas resection, accompanying illnesses, whether or not adjuvant therapy has been given, and the physical condition of the patient 相似文献
89.
C G Arruda J M Aldrighi L A Bortolotto I N Alecrin J A F Ramires 《Gynecological endocrinology》2006,22(10):557-563
BACKGROUND: Arterial hypertension and postmenopausal reduction of estrogen levels may be involved in modifications of the stiffness of large arteries. OBJECTIVES: To evaluate the pulse-wave velocity (PWV) and indirectly the arterial stiffness in hypertensive postmenopausal women submitted to hormone therapy with estradiol alone or combined with norethisterone acetate. SUBJECTS: Forty-five hypertensive postmenopausal women were double-blindly, randomly assigned to three arms of treatment: placebo (group I); estradiol 2 mg/day (group II); or estradiol 2 mg/day and norethisterone acetate 1 mg/day (group III). METHODS: Arterial stiffness was assessed from PWV measurements of the common carotid and femoral arteries (CF-PWV) and the common carotid and radial arteries (CR-PWV) obtained using the automatic Complior(R) device, taken at baseline and after 12 weeks of treatment. RESULTS: After the 12-week treatment, values of CF-PWV and CR-PWV were not significantly different (p = 0.910 and p = 0.736, respectively) among the groups. Systolic blood pressure showed a positive correlation with CF-PWV in groups II and III (p = 0.02 and p < 0.001, respectively). CONCLUSIONS: PWV and arterial stiffness in postmenopausal hypertensive women did not reduce over a 12-week treatment with estradiol alone compared with the same period of treatment with estradiol combined with norethisterone acetate. 相似文献
90.